Displaying drugs 7501 - 7525 of 12991 in total
4,4'-Biphenyldiboronic Acid
Experimental
Matched Iupac: … [4'-(dihydroxyboranyl)-[1,1'-biphenyl]-4-yl]boronic acid …
4-(4-Chlorophenyl)Imidazole
Experimental
Matched Name: … 4-(4-Chlorophenyl)Imidazole …
Matched Iupac: … 5-(4-chlorophenyl)-1H-imidazole …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Iupac: … 5-(4-chlorophenyl)-1H-imidazole …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
4,4'-Dihydroxybenzophenone
Experimental
Matched Synonyms: … Bis(4-hydroxyphenyl) ketone …
Matched Iupac: … 4-(4-hydroxybenzoyl)phenol …
Matched Iupac: … 4-(4-hydroxybenzoyl)phenol …
1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)
Experimental
Matched Name: … 1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE) …
Matched Iupac: … N-[(2S)-4,4,4-trifluoro-3-oxo-1-phenylbutan-2-yl]acetamide …
Matched Iupac: … N-[(2S)-4,4,4-trifluoro-3-oxo-1-phenylbutan-2-yl]acetamide …
Rovatirelin
Rovatirelin is under investigation in clinical trial NCT01384435 (A Phase II Double Blind Comparative Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)).
Investigational
Matched Iupac: … (4S,5S)-5-methyl-N-[(2S)-1-[(2R)-2-methylpyrrolidin-1-yl]-1-oxo-3-(1,3-thiazol-4-yl)propan-2-yl]-2-oxo ... -1,3-oxazolidine-4-carboxamide …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
Matched Categories: … Heterocyclic Compounds, 1-Ring …
NV-18
NV-18 is a product of the Novogen diphenolic synthetic analogue program that is creating drugs with diverse activities against specific types of cancer. Like phenoxodiol, NV-18 is broadly effective in the laboratory against almost all human cancer types, but NV-18 is distinctive in showing particular potency against melanoma and cholangiocarcinoma...
Investigational
PQ-10
Experimental
Matched Iupac: … 6,7-dimethoxy-4-[(3R)-3-(quinoxalin-2-yloxy)pyrrolidin-1-yl]quinazoline …
K-134
K-134 has been used in trials studying the treatment of Intermittent Claudication.
Investigational
Matched Iupac: … 1-cyclopropyl-1-[(1R,2R)-2-hydroxycyclohexyl]-3-{3-[(2-oxo-1,2-dihydroquinolin-6-yl)oxy]propyl}urea …
NT 13
Experimental
Matched Iupac: … (2S,3R)-2-{[(2S)-1-[(2S)-1-[(2S,3R)-2-amino-3-hydroxybutanoyl]pyrrolidine-2-carbonyl]pyrrolidin-2-yl] …
OT-15
Investigational
Dehydroascorbic acid
Dehydroascorbic acid is made from the oxidation of ascorbic acid. This reaction is reversible, but dehydroascorbic acid can instead undergo irreversible hydrolysis to 2,3-diketogulonic acid. Dehydroascorbic acid as well as ascorbic acid are both termed Vitamin C, but the latter is the main form found in humans. In the body,...
Experimental
4-(4-FLUOROBENZYL)PIPERIDINE
Experimental
Matched Name: … 4-(4-FLUOROBENZYL)PIPERIDINE …
Matched Iupac: … 4-[(4-fluorophenyl)methyl]piperidine …
Matched Iupac: … 4-[(4-fluorophenyl)methyl]piperidine …
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
Experimental
Matched Name: … 4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline …
Matched Iupac: … 3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol …
Matched Iupac: … 3-[(6,7-dimethoxyquinazolin-4-yl)amino]phenol …
COVID-19 Nucleocapsid-GM-CSF Protein Lactated Ringer's Injection
As of July 2020, Medicine Invention Design, Inc. is sponsoring a small, controlled clinical trial for the COVID-19 AP TP Vaccine for ‘proof of concept.’ The vaccine utilizes granulocyte macrophage-colony stimulating factor (GM-CSF), a cytokine known to enhance vaccine efficacy through prolongation of humoral and cell immunity.
Investigational
Idraparinux
Idraparinux, a synthetic pentasaccharide is an antithrombin-dependent inhibitor of activated factor X. It was developed for the treatment and prevention of thromboembolic events. However, clinical trials have revealed that idraparinux had lead to bleeding. As a result, Sanofi stopped the development of the drug.
Investigational
Matched Iupac: … (2S,3S,4S,5R,6R)-6-{[(2R,3R,4S,5R,6R)-6-{[(2R,3S,4S,5R,6R)-2-carboxy-4,5-dimethoxy-6-{[(2R,3R,4S,5R,6S ... yl]oxy}oxan-3-yl]oxy}-4,5-bis(sulfooxy)-2-[(sulfooxy)methyl]oxan-3-yl]oxy}-4,5-dimethoxy-3-{[(2R,3R,4S …
VX-702
VX-702 is a small molecule investigational oral anti-cytokine therapy for treatment of inflammatory diseases, specifically rheumatoid arthritis (RA). It acts as a p38 MAP kinase inhibitor. In the future, VX-702 may be investigated for combination with methotrexate, a commonly used therapy for RA.
Investigational
Matched Iupac: … 2-(2,4-difluorophenyl)-6-[1-(2,6-difluorophenyl)carbamoylamino]pyridine-3-carboxamide …
EC-17
Folate Fitc has been used in trials studying the diagnostic of Ovarian Cancer.
Investigational
Matched Iupac: … (2S)-2-[1-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}phenyl)-N-{2-[({3',6'-dihydroxy-3 ... -oxo-3H-spiro[2-benzofuran-1,9'-xanthene]-5-yl}carbamothioyl)amino]ethyl}formamido]-4-carbamoylbutanoic …
GB-13
GB-13 is a genetically engineered recombinant protein consisting of an IL13Ra2-targeted genetically engineered mutant of IL-13 and PE4E, a derivative of Pseudomonas exotoxin A.
Investigational
UV1
UV1 is a cancer vaccine consisting of p719-20, p728, and p725 synthetic peptides representing fragments of the hTERT subunit
Investigational
D-Mannuronic Acid
Experimental
Matched Iupac: … (2S,3S,4S,5S,6S)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid …
beta-D-Galactopyranuronic acid
Experimental
Matched Iupac: … (2S,3R,4S,5R,6R)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid …
L-Threonohydroxamate 4-Phosphate
Experimental
Matched Name: … L-Threonohydroxamate 4-Phosphate …
Matched Iupac: … [(2S,3R,4S)-2,3,4-trihydroxy-4-(hydroxyamino)butoxy]phosphonic acid …
Matched Iupac: … [(2S,3R,4S)-2,3,4-trihydroxy-4-(hydroxyamino)butoxy]phosphonic acid …
Hydroxypropyl tetrahydropyrantriol
Hydroxypropyl tetrahydropyrantriol has been used in trials studying the basic science of Aging.
Investigational
Matched Iupac: … (2S,3R,4S,5R)-2-(2-hydroxypropyl)oxane-3,4,5-triol …
Displaying drugs 7501 - 7525 of 12991 in total